Penicillin Allergy Delabeling Part II: A Case Based Discussion

Original release date: April 4, 2025; Termination date: April 3, 2028.

Download the webinar slides as full page slides or in handout format.

Continuing Education Credit(s)

This webinar has been approved for 1 AMA PRA Category 1 Credit™.

To request a certificate, first view the Penicillin Allergy Delabeling Part 2 webinar and the resources for further study and then complete the Evaluation/Certificate Request Form. Physicians will receive a CME Certificate and other learners will receive a Certificate of Attendance*

Webinar Overview

This activity is designed for healthcare providers, including physicians and pharmacists. Through case studies, participants will learn to identify appropriate candidates for an oral amoxicillin challenge, manage rare reactions during the challenge and counsel patients appropriately. The activity will also address strategies for implementing penicillin allergy delabeling in hospitals.

Part I, a CME activity on penicillin allergy delabeling (including benefits, guidelines, and patient selection), is also available.

Target Audience

This activity is designed for healthcare providers including physicians, pharmacists, infection preventionists or other facility antibiotic stewardship stakeholders.

Learning Objectives

At the conclusion of the webinar, participants will will feel more confident in their ability to:
  1. Safely perform an amoxicillin challenge and manage adverse events.
  2. Perform patient counseling following the delabeling procedure.
  3. Implement a penicillin allergy delabeling program.

Webinar Presenter

Shazia Lutfeali, MD

Shazia Lutfeali, MD, Allergy and Immunology Assistant Professor, Departments of Medicine and Pediatrics Cedars-Sinai Medical Center.

Dr. Lutfeali treats both hospitalized and clinic patients with a variety of allergic and immunologic conditions including drug allergies, food allergies, environmental allergies, chronic hives, severe asthma, and atopic dermatitis. During her training, she developed a strong interest in drug allergy and specifically the importance of penicillin allergy delabeling. Her research focused on rates of penicillin allergy relabeling and methods to prevent inappropriate allergy relabeling.


Resources for Further Study

LAC DPH Penicillin Allergy Delabeling Toolkit for Hospitals
LAC DPH Antimicrobial Stewardship Program homepage

Accreditation Statement

California Medical Association accredited CME provider logo

The Los Angeles County Department of Public Health is accredited by the California Medical Association (CMA) to provide continuing medical education for physicians.

The Los Angeles County Department of Public Health designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

*Other learners receive a Certificate of Attendance. Participation in CE coursework designated for AMA PRA Category 1 Credits™ is considered acceptable CE by the CA Board of Registered Nursing and the CA Board of Pharmacy if the coursework pertains to the practice of nursing or pharmacy respectively. Please contact your board with questions.

Disclosure

No relevant financial relationships were disclosed by the authors or the planners. This activity is offered by an accredited CMA-CME provider and is not commercially supported.

Contact Information